Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Parkinson's Disease

Free Subscription 24.11.2025 3 J Neural Transm (Vienna) 1 Lancet Neurol 5 Mov Disord 3 Neurobiol Dis 1 Neurochem Res 1 Neurol Genet 1 Neuroscience 3 PLoS One 1 Proc Natl Acad Sci U S A 2 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

J Neural Transm (Vienna)

1. INEICHEN C, Callaghan F, Baumann-Vogel H, Buchele F, et al
   A transdiagnostic structural brain signature of Parkinsonian and Essential Tremor.
   J Neural Transm (Vienna). 2025 Nov 21. doi: 10.1007/s00702-025-03067.
   PubMed         Abstract available
   
   
2. SPOA M, Monti S, Bjekic J, Guerra A, et al
   Resting-state EEG changes associated with cognitive decline in Parkinson's disease: a systematic review.
   J Neural Transm (Vienna). 2025 Nov 18. doi: 10.1007/s00702-025-03065.
   PubMed         Abstract available
   
   
3. SANTOS-GARCIA D, Solleiro A, Gonzalez-Ortega G, Mir P, et al
   Impact of device-aided therapies on quality of life in patients with Parkinson's disease. A comparative multicenter observational study.
   J Neural Transm (Vienna). 2025 Nov 18. doi: 10.1007/s00702-025-03066.
   PubMed         Abstract available
   
   

   
   Lancet Neurol

4. MARTINEZ-FERNANDEZ R, Paschen S, Deuschl G, Obeso JA, et al
   Focused ultrasound pallidothalamic tractotomy for Parkinson's disease: the field is moving fast.
   Lancet Neurol. 2025;24:996-997.
   PubMed        
   
   

   
   Mov Disord

5. YANG S, Zhu Y, Yu P, Huang Y, et al
   Dysfunctional Alternative Polyadenylation Modifies the Penetrance of LRRK2 Variants in Parkinson's Disease.
   Mov Disord. 2025 Nov 15. doi: 10.1002/mds.70119.
   PubMed         Abstract available
   
   
6. PARLAR SC, Lee Y, Gan-Or Z
   GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease Susceptibility.
   Mov Disord. 2025 Nov 15. doi: 10.1002/mds.70127.
   PubMed         Abstract available
   
   
7. AUBIGNAT M
   Unilateral Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Pallidothalamic Tractotomy in Parkinson's Disease: Promising Results But Uncertain Target.
   Mov Disord. 2025 Nov 18. doi: 10.1002/mds.70131.
   PubMed        
   
   
8. IKEZAWA J, Yokochi F, Yamaguchi T, Abe K, et al
   Reply: "Unilateral Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Pallidothalamic Tractotomy in Parkinson's Disease: Promising Results But Uncertain Target".
   Mov Disord. 2025 Nov 18. doi: 10.1002/mds.70130.
   PubMed        
   
   
9. MARK JR, Staley HA, Titus AM, Agin-Liebes J, et al
   Parkinson's-Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa.
   Mov Disord. 2025 Nov 19. doi: 10.1002/mds.70123.
   PubMed         Abstract available
   
   

   
   Neurobiol Dis

10. YIN P, Guan C, Niu X, Yang L, et al
    Corneal nerve loss measured by corneal confocal microscopy predicts pain severity in Parkinson's disease.
    Neurobiol Dis. 2025;217:107197.
    PubMed         Abstract available
    
    
11. DELIGANI RJ, Opri E, Risk BB, Goldstein F, et al
    Cortical beta power modulation is asymmetric and reduced during movement execution and inhibition in Parkinson's disease.
    Neurobiol Dis. 2025;217:107195.
    PubMed         Abstract available
    
    
12. AUNG KZ, Zin SS, Wu X, Myint ZW, et al
    Disentangling the inverse relationship between cancer and Alzheimer's or Parkinson's disease: A systematic review on Mendelian randomization studies.
    Neurobiol Dis. 2025;217:107190.
    PubMed         Abstract available
    
    

    
    Neurochem Res

13. HAN B, Bai J
    Mitochondrial Calcium Channels and MAM Interaction in Calcium Homeostasis Dysregulation in Parkinson's Disease.
    Neurochem Res. 2025;50:361.
    PubMed         Abstract available
    
    

    
    Neurol Genet

14. ALHUSAINI S, Dayanim G, Kandil M, Krohn L, et al
    Parkinson Disease SNCA Risk Variants Are Associated With Higher Asymmetric Putamen Dopaminergic Dysfunction.
    Neurol Genet. 2025;11:e200327.
    PubMed         Abstract available
    
    

    
    Neuroscience

15. SI Q, Shi J, Cao X, Gan C, et al
    Alterations in cortical sulcal morphology in Parkinson's disease patients with impulse control disorders.
    Neuroscience. 2025;591:149-156.
    PubMed         Abstract available
    
    

    
    PLoS One

16. BURGOS PI, Liu W, Silva-Batista C, Baker-Alcala F, et al
    Personalized versus fixed tactile cueing in Parkinson's disease: Protocol for a randomized controlled trial on gait automaticity.
    PLoS One. 2025;20:e0336859.
    PubMed         Abstract available
    
    
17. WEN J, Chen A, Liu J, Xiong H, et al
    Cross-modal fusion of brain imaging and clinical data for Parkinson's disease progression prediction.
    PLoS One. 2025;20:e0333822.
    PubMed         Abstract available
    
    
18. DENNIS AP, Martin SL, Chen R, Gerretsen P, et al
    Using machine learning for detection of Parkinson's disease and mild cognitive impairment.
    PLoS One. 2025;20:e0335541.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

19. PASCHOU C, Apokotou O, Charmpi K, Kollias A, et al
    Dysregulated proteostasis in p.A53T-alpha-Synuclein astrocytes aggravates Lewy-like neuropathology in a Parkinson's disease iPSC model.
    Proc Natl Acad Sci U S A. 2025;122:e2505240122.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

20. GRASS L, Grimaldi S, Damier P
    Prodromal Parkinson's disease.
    Rev Neurol (Paris). 2025;181:863-880.
    PubMed         Abstract available
    
    
21. COHEN M
    Digital health in presymptomatic diseases.
    Rev Neurol (Paris). 2025;181:937-943.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.